Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term adherence and response to botulinum toxin in different indications.
Ann Clin Transl Neurol. 2021 Jan;8(1):15-28. doi: 10.1002/acn3.51225. Epub 2020 Dec 1.
Ann Clin Transl Neurol. 2021.
PMID: 33259153
Free PMC article.
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group.
Comi G, et al.
Mult Scler. 2010 Feb;16(2):197-207. doi: 10.1177/1352458509357065. Epub 2009 Dec 22.
Mult Scler. 2010.
PMID: 20028707
Clinical Trial.
Item in Clipboard
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study.
O'Connor P, Comi G, Montalban X, Antel J, Radue EW, de Vera A, Pohlmann H, Kappos L; FTY720 D2201 Study Group.
O'Connor P, et al.
Neurology. 2009 Jan 6;72(1):73-9. doi: 10.1212/01.wnl.0000338569.32367.3d.
Neurology. 2009.
PMID: 19122034
Clinical Trial.
Item in Clipboard
Cite
Cite